These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18210126)

  • 21. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis.
    Kwak C; Kim HK; Kim EC; Choi MS; Kim HH
    Eur Urol; 2003 Oct; 44(4):475-81. PubMed ID: 14499684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Siener R; Bangen U; Sidhu H; Hönow R; von Unruh G; Hesse A
    Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hydrochlorothiazide and diet in dogs with calcium oxalate urolithiasis.
    Lulich JP; Osborne CA; Lekcharoensuk C; Kirk CA; Allen TA
    J Am Vet Med Assoc; 2001 May; 218(10):1583-6. PubMed ID: 11393368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion.
    Hatch M; Cornelius J; Allison M; Sidhu H; Peck A; Freel RW
    Kidney Int; 2006 Feb; 69(4):691-8. PubMed ID: 16518326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
    Hoppe B; Niaudet P; Salomon R; Harambat J; Hulton SA; Van't Hoff W; Moochhala SH; Deschênes G; Lindner E; Sjögren A; Cochat P
    Pediatr Nephrol; 2017 May; 32(5):781-790. PubMed ID: 27924398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of dietary hydroxyproline and dietary oxalate on urinary oxalate excretion in cats.
    Dijcker JC; Hagen-Plantinga EA; Thomas DG; Queau Y; Biourge V; Hendriks WH
    J Anim Sci; 2014 Feb; 92(2):577-84. PubMed ID: 24664562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.
    Holmes RP; Knight J; Assimos DG
    Urolithiasis; 2016 Feb; 44(1):27-32. PubMed ID: 26614109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting endogenous oxalate synthesis and its excretion in feces and urine in rats.
    Ribaya JD; Gershoff SN
    J Nutr; 1982 Nov; 112(11):2161-9. PubMed ID: 7131093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6.
    Hatch M
    Urolithiasis; 2020 Feb; 48(1):1-8. PubMed ID: 31201468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and identification of oxalate-degrading bacteria in human feces.
    Kodama T; Akakura K; Mikami K; Ito H
    Int J Urol; 2002 Jul; 9(7):392-7. PubMed ID: 12165021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxalic acid metabolism in the rat.
    Hodgkinson A
    J Nutr; 1978 Jul; 108(7):1155-61. PubMed ID: 660307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary obesity caused by a specific circadian eating pattern.
    Hariri N; Thibault L
    Chronobiol Int; 2011 Apr; 28(3):216-28. PubMed ID: 21452917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxalobacter formigenes and its role in oxalate metabolism in the human gut.
    Stewart CS; Duncan SH; Cave DR
    FEMS Microbiol Lett; 2004 Jan; 230(1):1-7. PubMed ID: 14734158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxalobacter formigenes and its potential role in human health.
    Duncan SH; Richardson AJ; Kaul P; Holmes RP; Allison MJ; Stewart CS
    Appl Environ Microbiol; 2002 Aug; 68(8):3841-7. PubMed ID: 12147479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of lipogenesis in the development of obesity and diabetes in Israeli sand rats (Psammomys obesus).
    Lewandowski PA; Cameron-Smith D; Jackson CJ; Kultys ER; Collier GR
    J Nutr; 1998 Nov; 128(11):1984-8. PubMed ID: 9808653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans.
    Hess B; Jost C; Zipperle L; Takkinen R; Jaeger P
    Nephrol Dial Transplant; 1998 Sep; 13(9):2241-7. PubMed ID: 9761503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion.
    Knight J; Easter LH; Neiberg R; Assimos DG; Holmes RP
    Urol Res; 2009 Apr; 37(2):63-8. PubMed ID: 19183980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.